CLINICAL_TRIALS
trial_result
· 2012-06-06
Clinical Trial Update: Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer [Phase 2]
Summary
A Phase 2 clinical trial evaluating raloxifene for persistent or recurrent endometrial cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED